Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017

Details for Mechanism ID: 16678
Country/Region: Malawi
Year: 2015
Main Partner: Management Sciences for Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $5,752,376 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $229,464
Care: TB/HIV (HVTB) $345,462
Care: Pediatric Care and Support (PDCS) $391,800
Laboratory Infrastructure (HLAB) $68,600
Health Systems Strengthening (OHSS) $66,400
Prevention: HIV Testing and Counseling (HVCT) $939,376
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,289,423
Treatment: Adult Treatment (HTXS) $1,964,956
Treatment: Pediatric Treatment (PDTX) $456,895
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 173,701
CARE_NEW_DSD Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 41,755
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 186,471
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 173,626
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 74,637
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 74,592
HTC_TST_DSD By Test Result: Negative 2016 465,919
HTC_TST_DSD By Test Result: Positive 2016 43,407
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 509,326
HTC_TST_DSD Sum of Aggregated Age/Sex 15+ 2016 360,097
HTC_TST_DSD Sum of Aggregated Age/Sex <15 2016 149,229
HTC_TST_DSD Sum of Aggregated Age/Sex disaggregates 2016 509,326
HTC_TST_DSD Sum of Test Result disaggregates 2016 509,326
PMTCT_ARV_DSD Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 9,674
PMTCT_ARV_DSD Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 9,192
PMTCT_ARV_DSD Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 4,779
PMTCT_ARV_DSD Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 4,413
PMTCT_ARV_DSD Sum of New and Current disaggregates 2016 9,192
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 7,737
PMTCT_STAT_DSD By: Known positives at entry 2016 4,353
PMTCT_STAT_DSD By: Number of new positives identified 2016 5,322
PMTCT_STAT_DSD Number of new ANC and L&D clients 2016 83,105
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 78,952
PMTCT_STAT_DSD Sum of Positives Status disaggregates 2016 9,675
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 2,339
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 2,169
TB_SCREEN_DSD Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 173,701
TB_SCREEN_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 170,220
TX_CURR_DSD Age/Sex: 1-4 Female 2016 1,108
TX_CURR_DSD Age/Sex: 1-4 Male 2016 1,020
TX_CURR_DSD Age/Sex: 5-14 Female 2016 5,163
TX_CURR_DSD Age/Sex: 5-14 Male 2016 5,213
TX_CURR_DSD Age/Sex: <1 Female 2016 133
TX_CURR_DSD Age/Sex: <1 Male 2016 111
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2016 165,615
TX_CURR_DSD Sum of age/sex disaggregates 2016 165,615
TX_NEW_DSD By Age/Sex: 1-4 Female 2016 497
TX_NEW_DSD By Age/Sex: 1-4 Male 2016 563
TX_NEW_DSD By Age/Sex: 10-14 Female 2016 397
TX_NEW_DSD By Age/Sex: 10-14 Male 2016 340
TX_NEW_DSD By Age/Sex: 15-19 Female 2016 986
TX_NEW_DSD By Age/Sex: 15-19 Male 2016 265
TX_NEW_DSD By Age/Sex: 20-24 Female 2016 3,718
TX_NEW_DSD By Age/Sex: 20-24 Male 2016 459
TX_NEW_DSD By Age/Sex: 25-49 Female 2016 17,347
TX_NEW_DSD By Age/Sex: 25-49 Male 2016 10,134
TX_NEW_DSD By Age/Sex: 5-9 Female 2016 385
TX_NEW_DSD By Age/Sex: 5-9 Male 2016 450
TX_NEW_DSD By Age/Sex: 50+ Female 2016 1,374
TX_NEW_DSD By Age/Sex: 50+ Male 2016 1,663
TX_NEW_DSD By Age/Sex: <1 Female 2016 253
TX_NEW_DSD By Age/Sex: <1 Male 2016 235
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 39,066
TX_NEW_DSD Pregnancy status 2016 8,510
TX_NEW_DSD Sum of Age/Sex disaggregates 2016 39,066
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 31,251
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 39,066
Cross Cutting Budget Categories and Known Amounts Total: $300,000
Human Resources for Health $50,000
Key Populations: MSM and TG $250,000
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for MSM/TG
Training of health workers and community outreach workers